Damon Runyon News

June 10, 2019
Latest News

Henry T. Lynch, MD (Damon Runyon Grantee 1969-70), father of cancer genetics, has passed away at age 91, leaving behind a lasting legacy in cancer research and treatment. When Dr. Lynch began his career, most scientists blamed cancer on environmental causes, such as the presence of carcinogenic chemicals and viruses. Hereditary explanations were dismissed, even shunned. His painstaking research putting together family histories established that certain cancers are hereditary. Today genetic screening is an important part of cancer prevention, saving thousands of lives.

June 6, 2019
Latest News

The Damon Runyon Cancer Research Foundation honored William M. Raveis, Jr., Chairman and CEO, William Raveis Real Estate, Mortgage & Insurance, for his transformational support and commitment to raising funds and awareness for Damon Runyon.

May 28, 2019

Mark G. Shrime, MD, PhD, MPH, is a Damon Runyon Clinical Investigator who will compete on the upcoming season of NBC's American Ninja Warrior (Season premieres on Wednesday, May 29 at 8/7c on NBC). 

May 22, 2019
Awards and Honors

Adrienne A. Boire, MD, PhD (Damon Runyon Clinical Investigator ’17-’20), and Alex Kentsis, MD, PhD (Damon Runyon Clinical Investigator ’16-’19), both of Memorial Sloan Kettering Cancer Center, New York, each received a 2019 Pershing Square Sohn Prize for Young Investigators in Cancer Research. Recipients receive $200,000 per year for up to three years and  opportunities to present their work to scientific and business audiences, helping to bridge the gap between the academic and business communities. 

May 20, 2019
Latest News

“It is unthinkable that a doctor could tell you that there is nothing that can be done for your child,” says Damon Runyon-Sohn Pediatric Cancer Fellow Kathryn R. Taylor, PhD, of Stanford University School of Medicine. But that is the reality for hundreds of families who are facing a devastating pediatric brain cancer diagnosis called glioma. “We now know that pediatric cancers are not the same as their corresponding adult cancers and may require different treatments. I chose to study the unique biology of pediatric tumors as a developmental disease because it is key to finding effective therapies,” says Kathryn. Her research focuses on how glioma cells use signals in the surrounding brain tissue to promote their own growth.

May 17, 2019
Latest News

​(Bronx, NY)  More than 2,150 people from across the country and abroad took part in the 11th Annual Runyon 5K at Yankee Stadium on Saturday, May 11, 2019, raising nearly $400,000 to support breakthrough cancer research by today’s best young scientists, funded by the Damon Runyon Cancer Research Foundation. Since the inaugural event in 2009, the annual Runyon 5K has raised more than $5.5 million.

May 15, 2019
Latest News

(New York, NY)  To help increase the number of physician-scientists, the Damon Runyon Cancer Research Foundation created the Damon Runyon Physician-Scientist Training Award, which provides physicians who have earned an MD degree and completed clinical specialty fellowship training the opportunity to gain the research experience they need to become leaders in translational and clinical research. Damon Runyon announced that six scientists with novel approaches to fighting cancer have been named the 2019 recipients of the award.

May 10, 2019
New Discovery

The five-year survival rate for leukemia has almost doubled in the past 45 years. Still, about 20 percent of children and more than half of adults with leukemia fail to respond to treatment or form drug resistance and eventually succumb to the disease. New findings published in the journal Cancer Cell from Former Damon Runyon Clinical Investigator Alejandro Gutierrez, MD, and his colleagues at Boston Children’s Hospital offer hope to these vulnerable leukemia patients. 

May 7, 2019

Guest Author: Marissa Rashkovan, PhD, Damon Runyon-Sohn Pediatric Cancer Fellow

On my 14th birthday, my parents sat my brother and me down and let us know that my mom had cancer – non-Hodgkin’s Lymphoma to be exact. At the time, I didn’t know what that was. 

May 1, 2019
Awards and Honors

Five Damon Runyon alumnae were elected to the National Academy of Sciences (the science “Hall of Fame”), one of the highest honors given to a U.S. scientist. This membership recognizes their distinguished and continuing achievements in biomedical research. The total number of Damon Runyon scientists who are members of the National Academy of Sciences is now 79. This is a milestone year with women comprising 40 percent of the 100 newly elected members and 25 foreign associates, the most ever elected in any one year since the Academy was established in 1863.